Could your own blood ease hip pain? PRP injection shows promise
NCT ID NCT06332352
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a single injection of platelet-rich plasma (PRP) into the hip joint can relieve pain and improve function in people with a torn hip labrum. Thirty adults aged 18 to 49 who had not improved with standard care received the injection. Researchers tracked their pain, hip function, and overall health using surveys over six months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- platelet-rich plasma (PRP)
- What this could lead to
- If it works, this could offer a non-surgical option to reduce hip pain and improve daily function for people with labral tears.
- What could go wrong
- This is a small, completed study with only 30 participants and no comparison group, so results may not apply widely. PRP injections can cause temporary pain or swelling.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Mar 2024
- Finished
-
Mar 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 49 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≤49 years old (i.e., 18 - 49 years old) * Hip or groin pain with at least 1 positive provocative labral hip maneuver (i.e., Flexion, Adduction, Internal Rotation (FADIR) test, subspine impingement test, scour) * Radiographs with Tonnis grade \< 2 (i.e., 0 or 1) * MRI or MRA hip with evidence of acetabular labral tear * Failure of at least 6 weeks of conservative management \[i.e., activity modification, non-steroidal anti-inflammatory drugs (NSAIDs), and/or physical therapy (PT), other intra-articular injection etc.\] * Prior diagnostic ultrasound guided hip injection with anesthetic-only providing ≥50% pain relief Exclusion Criteria: * Any prior surgery to the affected hip * Imaging with evidence of avascular necrosis of the affected hip * Imaging with evidence of hip dysplasia (i.e. lateral center edge angle of ≤20 degrees) * Alpha angle of ≥55 degrees of the affected hip * Intra-articular hip injection within the last 6 months to the affected hip of any injectate with the exception of anesthetic * Active systemic infection requiring antibiotics or local infection at the site of the injection * Any prior intra-articular infection of the affected hip * Any prior fracture of the affected femur or pelvis * Blood dyscrasia or malignancy * Non-ambulatory patients * Patient seeking care with active litigation pending * Body mass index (BMI) ≥ 35 kg/m2 * Systemic inflammatory arthropathy * Oral steroids consumed within the last three months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acetabular labrum tear are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Utah - Department of Orthopaedics
Salt Lake City, Utah, 84108, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.